https://www.selleckchem.com/pr....oducts/pargyline-hyd
34 MME/month vs. post b=0.12 MME/month). For 51-100 MME, the pre- and post-guideline dose slopes did not significantly differ (pre b=0.60 MME/month vs. post b=0.27 MME/month). For 101-200 MME, post-guideline dose slope was significantly (p0.0001) steeper and decreasing post-guideline (pre b=0.11 MME/month vs. post b= -1.33 MME/month). Among 200 MME, dose decreased in the pre- and post-guideline periods, and post-guideline decline was significantly (p0.0001) steeper (b= -1. 86 MME/month vs. b= -4.13 MME/month)
Like
Comment
Share
